be_ixf;ym_202512 d_21; ct_50
NASDAQ:ARM charts & data provided by TradingView

Latest Insights on ARM

Today’s Reader Feedback is a lesson in market patience — just a little patience, yeah — and a dive into biotech, Nio, Facebook and oil. Apocalypse Someday, Nio Nerves and Forgetting Facebook November 5, 2020 by Joseph Hargett Great Stuff Market Apocalypse Now? Welcome to Great Stuff’s Reader Feedback day. This day is all about you our loyal readers. We answer your questions — market-related or not — and indulge in your rants. Why? Because Great Stuff has the best readers of any financial rag on the internet. It’s why we call you the Great […]
Election results, pandemic responses and October jobs data … man it’s a busy week. And we didn't even mention earnings season yet. Election Forecasts; Clorox’s Clean Sweep; Nio the Golden Child November 2, 2020 by Joseph Hargett Great Stuff It’s the Final Countdown! We are close, Great Ones! One of the major cogs in the vast volatility machine is about to be put out of commission. Election day is tomorrow. While I don’t expect a clear winner before the day is up, we should be able to put this uncertainty driver to bed very […]
You know what they say about baseball card collecting in the ‘80s and the stock market. Well, maybe you don’t, but it ain’t pretty… Winter Is Coming; Forests of Azure, Cloudless Solar Skies October 28, 2020 by Joseph Hargett Great Stuff Future in the Cards Sooo … how about those Dodgers? I don’t follow baseball — I got burned on baseball cards back in the late ‘80s and early ‘90s, and it’s been downhill ever since. Anyone else have a massive box of three-decades-old baseball cards that are worth absolutely nothing right now? Oddly enough, there’s […]
Invest in Biotech With 1 Buy October 27, 2020 by Chad Shoop 2020 Financial Crisis, American Investor Today (9-minute video) In the war against COVID-19, American biotech companies are paving the path. The latest success is Gilead’s remdesivir winning FDA approval. Will this be the start of a new uptrend for the stock?
An unexpected decline in new home sales and spiking COVID cases spooked Wall Street. But you Great Ones have options to ride out this storm. Pandemic Options; Billionaire Ant Hill; Dunkin Munchkin Huntin’ October 26, 2020 by Joseph Hargett Great Stuff Risk on; Risk off The global economy is sick … and I mean that literally, not in the ‘90s kinda way or in a Michael Jackson’s “Bad is good” kinda way. Over the weekend, the U.S. hit back-to-back record highs for new COVID-19 cases. According to Johns Hopkins University data, the seven-day average of new […]

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”

- Larry K.

“At the end of August [2018], my 401K was $659,000. Now, on September 4th [2018], it’s $715,000. My account is up $56,000 in the last 5 days!”

- Warren O

"You told me to ignore the noise on Wall Street. And thanks to you, I started towards the end of 2016 with $200,000 in my account and I recently put in an extra $100,000. [As of February 2019] My account is worth $500,788! I would’ve missed out if I followed conventional wisdom."

- Helen C.

Share This